Diffuse Intrinsic Pontine Glioma - 26 Studies Found

Recruiting : Molecular Profiling for Individualized Treatment Plan for DIPG
: Diffuse Intrinsic Pontine Glioma (DIPG)
: 2014-10-21
:
  • Other: Specialized tumor board recommendation

Completed : Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma
: Recurrent Diffuse Pontine Gliomas
: 2008-01-11
: Biological: nimotuzumab (anti EGFR humanized monoclonal antibody) 150 mg/m2 I.V. Induction phase: infusi
Terminated : Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents
: Gliomas
: 2012-01-11
:
  • Drug: Cilengitide Cilengitide

Recruiting : Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine Glioma
:
  • Glioblastoma (GBM)
  • DIPG

: 2016-04-27
: Drug: Doxorubicin
RECRUITING : FUS Etoposide for DMG - A Feasibility Study
: Diffuse Intrinsic Pontine Glioma
: 2024-11-21
: Subjects will receive focused ultrasound sonication followed by once daily oral etoposide (50mg/m^2/dose).Oral etoposide will be taken
RECRUITING : Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System Tumors
: Diffuse Intrinsic Pontine Glioma
: 2024-11-21
: Courses of weekly intravenous SC-CAR4BRAIN infusions for 3 weeks, then 1 week off
<<< Previous